Marinus Pharmaceuticals Inc.
MRNS
|
|
| |
|
| Trading Volume | 28,167 |
|
|
11.21 - 1.10 |
| Market Cap Full | $ 77.5M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 0.6% | -17% | 73.4% | -21.2% |
| Q2 | - | -86.3% | 57.4% | -48.3% |
| Q3 | - | 1.4% | -25.9% | 37.4% |
| Q4 | - | 79.5% | 44.2% | -40.2% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.6 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -10.4 | -2.5 | -5.1 | -84.9 | 3.7 | -12.8 | 13.8 | 1.4 | - | - | - | - |
| 2023 | |||||||||||
| 59.6 | 8.7 | - | 31.9 | -21.9 | 52.7 | -2 | -33.2 | 13.2 | -13.8 | -3 | 61.5 |
| 2022 | |||||||||||
| -14.1 | -24 | 20.8 | -29.3 | -26.7 | -0.2 | 15.1 | 25 | -4.5 | -13.5 | -16.7 | -16.9 |
| 2021 | |||||||||||
| 2.1 | 21.7 | 2.3 | -4.8 | 14.1 | 6.7 | -18.1 | -15.9 | -5.6 | -1.5 | -3.4 | 6.9 |
| 2020 | |||||||||||
| -7.7 | 21.2 | -17.5 | 0.5 | 24.5 | - | -33.9 | 15.5 | 562.4 | 1.7 | 20.9 | -22.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.7 | -0.5 | -0.7 | -1.3 |
| Q2 | -0.6 | -1.1 | -0.7 | -0.6 |
| Q3 | -0.6 | 1.9 | -0.5 | -0.5 |
| Q4 | 0 | -0.8 | -0.8 | -0.4 |
| A | -1.89 | -0.5 | -2.7 | -2.8 |